What You Should Know:
– Helio Genomics, an AI-driven healthcare company specializing in diagnostics technology for cancer detection, has appointed Gary Frazier as its Chief Growth Officer.
– Frazier’s appointment at Helio Genomics underscores the company’s commitment to strategic growth and innovation. His leadership will be instrumental in shaping the firm’s trajectory, including strategic business planning, growth strategies, integrated delivery systems, and more.
Gary Frazier Bio/Background
Frazier is the visionary behind Worksite Labs, a groundbreaking diagnostic laboratory company that has evolved into one of the largest decentralized laboratory networks in the United States. Additionally, he founded OM Healthcare, a digital front door software facilitating direct-to-consumer healthcare services. Frazier’s professional journey includes pivotal roles such as Vice President of Mergers and Acquisitions at Paladin Healthcare, where he spearheaded marketing and business strategies for potential mergers and acquisitions across the nation. Moreover, his tenure as Vice President of Strategy and Business Development at Dignity Health involved strategic planning and growth initiatives for multiple hospitals in central California.
With over two decades of experience in business development and expertise spanning hospital and health system management, Frazier is recognized for his thought leadership in advancing healthcare strategy, technology, and innovation. His insights have contributed to increased access to quality care and leveled the playing field for patients.
“We are very pleased to welcome Gary to the Helio team,” said Helio Genomics CEO Justin Chen Li. “The impressive depth and breadth of his experience in the healthcare sector are a perfect match for our strategic direction. We look forward to his contributions in helping us achieve our goals for transforming early cancer diagnosis and saving lives.”
